357 related articles for article (PubMed ID: 8140412)
1. Characterization of type I receptors for transforming growth factor-beta and activin.
ten Dijke P; Yamashita H; Ichijo H; Franzén P; Laiho M; Miyazono K; Heldin CH
Science; 1994 Apr; 264(5155):101-4. PubMed ID: 8140412
[TBL] [Abstract][Full Text] [Related]
2. Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors.
Attisano L; Cárcamo J; Ventura F; Weis FM; Massagué J; Wrana JL
Cell; 1993 Nov; 75(4):671-80. PubMed ID: 8242742
[TBL] [Abstract][Full Text] [Related]
3. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4.
ten Dijke P; Yamashita H; Sampath TK; Reddi AH; Estevez M; Riddle DL; Ichijo H; Heldin CH; Miyazono K
J Biol Chem; 1994 Jun; 269(25):16985-8. PubMed ID: 8006002
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of a type I serine-threonine kinase receptor for TGF-beta and activin in the rat pituitary tumor cell line GH3.
Takumi T; Moustakas A; Lin HY; Lodish HF
Exp Cell Res; 1995 Jan; 216(1):208-14. PubMed ID: 7813622
[TBL] [Abstract][Full Text] [Related]
5. Determination of type I receptor specificity by the type II receptors for TGF-beta or activin.
Ebner R; Chen RH; Lawler S; Zioncheck T; Derynck R
Science; 1993 Nov; 262(5135):900-2. PubMed ID: 8235612
[TBL] [Abstract][Full Text] [Related]
6. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin.
Cárcamo J; Weis FM; Ventura F; Wieser R; Wrana JL; Attisano L; Massagué J
Mol Cell Biol; 1994 Jun; 14(6):3810-21. PubMed ID: 8196624
[TBL] [Abstract][Full Text] [Related]
7. The p21(RAS) farnesyltransferase alpha subunit in TGF-beta and activin signaling.
Wang T; Danielson PD; Li BY; Shah PC; Kim SD; Donahoe PK
Science; 1996 Feb; 271(5252):1120-2. PubMed ID: 8599089
[TBL] [Abstract][Full Text] [Related]
8. Assignment of transforming growth factor beta1 and beta3 and a third new ligand to the type I receptor ALK-1.
Lux A; Attisano L; Marchuk DA
J Biol Chem; 1999 Apr; 274(15):9984-92. PubMed ID: 10187774
[TBL] [Abstract][Full Text] [Related]
9. Expression of transforming growth factor-beta1, activin A, and their receptors in thyroid follicle cells: negative regulation of thyrocyte growth and function.
Franzén A; Piek E; Westermark B; ten Dijke P; Heldin NE
Endocrinology; 1999 Sep; 140(9):4300-10. PubMed ID: 10465304
[TBL] [Abstract][Full Text] [Related]
10. Silencing of TGF-beta signalling by the pseudoreceptor BAMBI.
Onichtchouk D; Chen YG; Dosch R; Gawantka V; Delius H; Massagué J; Niehrs C
Nature; 1999 Sep; 401(6752):480-5. PubMed ID: 10519551
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor.
Persson U; Souchelnytskyi S; Franzén P; Miyazono K; ten Dijke P; Heldin CH
J Biol Chem; 1997 Aug; 272(34):21187-94. PubMed ID: 9261125
[TBL] [Abstract][Full Text] [Related]
12. GH3 pituitary tumor cells contain heteromeric type I and type II receptor complexes for transforming growth factor beta and activin-A.
Moustakas A; Takumi T; Lin HY; Lodish HF
J Biol Chem; 1995 Jan; 270(2):765-9. PubMed ID: 7822308
[TBL] [Abstract][Full Text] [Related]
13. Tumor-specific expression and alternate splicing of messenger ribonucleic acid encoding activin/transforming growth factor-beta receptors in human pituitary adenomas.
Alexander JM; Bikkal HA; Zervas NT; Laws ER; Klibanski A
J Clin Endocrinol Metab; 1996 Feb; 81(2):783-90. PubMed ID: 8636304
[TBL] [Abstract][Full Text] [Related]
14. Structural and functional evidence for a singular repertoire of BMP receptor signal transducing proteins in the lophotrochozoan Crassostrea gigas suggests a shared ancestral BMP/activin pathway.
Herpin A; Lelong C; Becker T; Rosa F; Favrel P; Cunningham C
FEBS J; 2005 Jul; 272(13):3424-40. PubMed ID: 15978047
[TBL] [Abstract][Full Text] [Related]
15. TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells.
Piek E; Moustakas A; Kurisaki A; Heldin CH; ten Dijke P
J Cell Sci; 1999 Dec; 112 ( Pt 24)():4557-68. PubMed ID: 10574705
[TBL] [Abstract][Full Text] [Related]
16. A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity.
Feng XH; Derynck R
EMBO J; 1997 Jul; 16(13):3912-23. PubMed ID: 9233801
[TBL] [Abstract][Full Text] [Related]
17. Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity.
ten Dijke P; Ichijo H; Franzén P; Schulz P; Saras J; Toyoshima H; Heldin CH; Miyazono K
Oncogene; 1993 Oct; 8(10):2879-87. PubMed ID: 8397373
[TBL] [Abstract][Full Text] [Related]
18. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily.
Barbara NP; Wrana JL; Letarte M
J Biol Chem; 1999 Jan; 274(2):584-94. PubMed ID: 9872992
[TBL] [Abstract][Full Text] [Related]
19. Truncated activin type II receptors inhibit bioactivity by the formation of heteromeric complexes with activin type I. receptors.
De Winter JP; De Vries CJ; Van Achterberg TA; Ameerun RF; Feijen A; Sugino H; De Waele P; Huylebroeck D; Verschueren K; Van Den Eijden-Van Raaij AJ
Exp Cell Res; 1996 May; 224(2):323-34. PubMed ID: 8612709
[TBL] [Abstract][Full Text] [Related]
20. Expression of TGF-beta superfamily receptors in dental pulp.
Toyono T; Nakashima M; Kuhara S; Akamine A
J Dent Res; 1997 Sep; 76(9):1555-60. PubMed ID: 9294489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
